HeXun Biosciences Co., Ltd. (TPEX:6986)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
82.30
-0.90 (-1.08%)
Apr 2, 2025, 1:45 PM CST
48.02%
Market Cap 3.86B
Revenue (ttm) 236.41M
Net Income (ttm) 124.21M
Shares Out 46.00M
EPS (ttm) 2.70
PE Ratio 31.11
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 79,460
Average Volume 576,675
Open 83.20
Previous Close 83.20
Day's Range 80.20 - 83.20
52-Week Range 54.20 - 91.30
Beta n/a
RSI 58.40
Earnings Date May 9, 2025

About HeXun Biosciences

HeXun Biosciences Co., Ltd. engages in the research and development of stem cell and treatments in Taiwan. It provides outsourced production services; commissioned development and manufacturing services for various cells and cell derivatives; commissioned inspection; advisory; laboratory information management system; and sterile filling services. The company was founded in 2019 and is based in Taoyuan City, Taiwan. [Read more]

Industry Commercial Physical and Biological Research
Founded 2019
Employees 35
Stock Exchange Taipei Exchange
Ticker Symbol 6986
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.